$GLAXO-IN News

Last published 2y ago

2y agoNVDA JPM MSFT AZN-GB+9Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternativeCNBCCerebras is playing in a huge market with insatiable investor demand, but its IPO prospectus is littered with red flags that complicate a potential debut.
2y agoNVDA MSFT AAPL INTC+6Nvidia dominates the AI chip market, but there's more competition than everCNBCCompanies are fighting for a piece of the AI chip market, which could reach $400 billion in annual revenue within five years.
3y agoGLAXO-INFDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risksCNBCA majority of the FDA panel said GSK's vaccine safety data was adequate, and the advisors were unanimous that the shot's efficacy was good.